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Objective: To explore the mechanism of osteoarthritis (OA) and provide valid biological information for
further investigation.
Methods: Gene expression proﬁle of GSE46750 was downloaded from Gene Expression Omnibus data-
base. The Linear Models for Microarray Data (limma) package (Bioconductor project, http://www.
bioconductor.org/packages/release/bioc/html/limma.html) was used to identify differentially expressed
genes (DEGs) in inﬂamed OA samples. Gene Ontology function enrichment analysis and Kyoto Ency-
clopedia of Genes and Genomes (KEGG) pathways enrichment analysis of DEGs were performed based
on Database for Annotation, Visualization and Integrated Discovery data, and proteineprotein interaction
(PPI) network was constructed based on the Search Tool for the Retrieval of Interacting Genes/Proteins
database. Regulatory network was screened based on Encyclopedia of DNA Elements. Molecular Complex
Detection was used for sub-network screening. Two sub-networks with highest node degree were in-
tegrated with transcriptional regulatory network and KEGG functional enrichment analysis was pro-
cessed for 2 modules.
Results: In total, 401 up- and 196 down-regulated DEGs were obtained. Up-regulated DEGs were
involved in inﬂammatory response, while down-regulated DEGs were involved in cell cycle. PPI network
with 2392 protein interactions was constructed. Moreover, 10 genes including Interleukin 6 (IL6) and
Aurora B kinase (AURKB) were found to be outstanding in PPI network. There are 214 up- and 8 down-
regulated transcription factor (TF)-target pairs in the TF regulatory network. Module 1 had TFs including
SPI1, PRDM1, and FOS, while module 2 contained FOSL1. The nodes in module 1 were enriched in
chemokine signaling pathway, while the nodes in module 2 were mainly enriched in cell cycle.
Conclusion: The screened DEGs including IL6, AGT, and AURKB might be potential biomarkers for gene
therapy for OA by being regulated by TFs such as FOS and SPI1, and participating in the cell cycle and
cytokineecytokine receptor interaction pathway.
© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Osteoarthritis (OA), also known as degenerative arthritis, is a
type of joint disease that results from breakdown of joint cartilage
and underlying bone.1 The most common symptoms of this disease
are joint pain and stiffness.2 So far, lifestyle modiﬁcations such as
weight loss and exercise, and analgesics are the mainstay of
treatment, but they only provide improvement in physical func-
tion.3 Therefore, it is important to research the mechanism of OA.dics, Shanghai First People's
edicine, No. 100 Haining Rd,
s and Traumatology. Publishing seEpidemiological mechanism of OA is complex and has multiple
factors including genetic, biological, and biomechanical compo-
nents.4 Recently, molecular mechanism of OA has been studied.
Interleukin 1 (IL-1) has been conﬁrmed as a critical factor that can
induce joint synovitis degeneration and articular cartilage degra-
dation.5 In addition, tumor necrosis factor-alpha has been proven to
activate multinucleated cells and stimulate synovial cells to pro-
duce prostaglandin E2 (PGE2), further attacking cartilage and
bone.6 Synovial membrane (SM) is traditionally considered part of
the joint capsule.7 The coexisting protein metabolism in SM has
been conﬁrmed to be involved in degradation of articular cartilage.8
Decreased expression of protein in T cells from SM of OA patients is
related to the progress of OA.9rvices by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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providing new opportunities to uncover potential disease-related
genes of SM associated with progression of OA.10,11 By investi-
gating the gene expression proﬁles of SM samples from early-stage
and end-stage OA patients, genes related to immune response,
cartilage development, protein glycosylation, and muscle devel-
opment have been revealed to be useful in diagnosis and treatment
of OA.10 One study on gene expression patterns of synovial cells
from inﬂamed and normal/reactive areas of SM demonstrated that
genes matrix metalloproteinase 3 (MMP3) and hyaluronan syn-
thase 1 (HAS1) were signiﬁcantly up-regulated and in pathways
such as cartilage catabolism pathway.11 Although there is a close
relationship between OA and SM alteration, potential disease-
related genes of OA based on SM samples are still unclear.
In order to research more molecular mechanisms of OA, a bio-
informatics analysis was performed in this study to explore genes
or proteins that could be potential targets in OA treatment based on
gene expression proﬁle.Patients and methods
Samples
Gene expression proﬁle data of GSE4675011 were downloaded
from Gene Expression Omnibus (GEO) database (http://www.ncbi.
nlm.nih.gov/geo/) based on platform GPL10558 Illumina
HumanHT-12 v4 Expression BeadChip (Illumina, Inc., San Diego, CA,
USA). Inﬂammation status of SM was classiﬁed as normal/reactive
or inﬂamed.11 A total of 24 samples derived from 12 knee OA pa-
tients were used for microarray data: 12 synovial tissue samples
from inﬂamed areas of SM, and 12 from normal/reactive areas of
SM in the same patients.Table 1Data preprocessing and differential expression analysis
Normalization of this data was performed using Robust Multi-
chip Average (RMA) method12 of “affy e analysis of Affymetrix
GeneChip data at the probe level” software package (Bioconductor
project, http://bioconductor.org/packages/release/bioc/html/affy.
html)13 and R statistical software (version 3.0.0; R Project for Sta-
tistical Computing, https://www.r-project.org/). Differentially
expressed genes (DEGs) in inﬂamed OA samples were then iden-
tiﬁed using Linear Models for Microarray Data (limma) package
(Bioconductor project, http://www.bioconductor.org/packages/
release/bioc/html/limma.html).14 P-value was adjusted using Ben-
jaminieHochberg method.15 Subsequently, adjusted P-value <0.05
and log2 fold change (FC) > 1 were selected as threshold value for
DEG screening.Results of Gene Ontology functional enrichment analysis of differently expressed
genes in osteoarthritis (Top 10 listed).
Category Term Description Count P-value
Up-regulated
BP GO:0006952 Defense response 82 3.15E38
BP GO:0006954 Inﬂammatory response 52 1.72E27
BP GO:0009611 Response to wound 62 2.52E25
BP GO:0006935 Chemotaxis 32 9.03E20
BP GO:0042330 Taxis 32 9.03E20
Down-regulated
BP GO:0000279 M phase 45 2.23E33
BP GO:0007049 Cell cycle 61 2.21E32
BP GO:0000280 Nuclear division 37 1.99E30
BP GO:0007067 Mitosis 37 1.99E30
BP GO:0022403 Cell cycle phase 46 3.67E30
BP: biological process; GO: Gene Ontology. P-value <0.05 and count >2 were
threshold values for signiﬁcant difference.Gene Ontology annotation and pathway analysis
The Database for Annotation, Visualization and Integrated Dis-
covery (DAVID; http://david.abcc.ncifcrf.gov/)16 is a functional
classiﬁcation tool that provides a set of functional annotation tools
for investigators to understand biological meaning behind large list
of genes. Gene Ontology (GO, http://www.geneontology.org)17
provides a common approach for functional studies of large-scale
genomic or transcriptomic data, which mainly consists of biolog-
ical process (BP), molecular function (MF), and cellular component
(CC). In this study, GO BP function enrichment analysis and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway enrichment
analysis of DEGs were performed based on DAVID data.16 P-value
<0.05 and count >2 were considered threshold values.Proteineprotein interaction (PPI) network construction
Search Tool for the Retrieval of Interacting Genes/Proteins
(STRING; http://string-db.org/) is a biological database of known
and predicted proteineprotein interactions.18 Protein interactions
were selected according to STRING database with combined score
>0.4 and proteineprotein interaction (PPI) network was con-
structed. Hub nodes withmany interaction partners were identiﬁed
in PPI network that were considered to be associated with devel-
opment of OA.
Prediction of transcriptional regulatory relationship
Encyclopedia of DNA Elements (ENCODE) Consortium database
(https://www.genome.gov/encode/) collects sequence-based
studies in order to map functional factors including RNA-
transcribed regions, transcription factor (TF) binding, and chro-
matin structure across the human genome.19 Regulatory network
was screened based on network data of TFs in ENCODE database.
Then, transcriptional regulation relationship was screened for
regulatory network construction by comparing it with PPI network.
Functional enrichment analysis of integrated sub-network.
Molecular Complex Detection (MCODE) clustering algorithm20
was used for sub-network screening with default threshold (de-
gree cutoff: 2; node score cutoff: 0.2; k-core: 2; max. depth: 100).
Two sub-networks with highest PPI network node degree were
integrated with transcriptional regulatory network. In addition,
KEGG functional enrichment analysis was processed to annotate
functions of TFs.
Results
Identiﬁcation of DEGs
Based on threshold of P-value<0.05 and log2FC> 1, a total of 401
up-regulated DEGs and 196 down-regulated DEGs were identiﬁed.
Functional enrichment analysis of DEGs
To gain further insight into function of the genes, signiﬁcant
enrichment functions of DEGs were annotated using DAVID tool. As
shown in Table 1, GO-BP functional enrichment analysis demon-
strated that up-regulated DEGs were primarily involved in defense
response (GO: 0006952; 82 DEGs) and inﬂammatory response (GO:
Table 2
Results of Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of differentially expressed genes in osteoarthritis (Top 8 listed).
Category Term Description Count P value
Up-regulated hsa04060 Cytokineecytokine receptor interaction 30 1.34E07
hsa04062 Chemokine signaling pathway 21 2.33E05
hsa04640 Hematopoietic cell lineage 15 3.49E06
hsa05322 Systemic lupus erythematosus 15 1.89E05
Down-regulated hsa04110 Cell cycle 11 4.48E07
hsa04115 P53 signaling pathway 6 6.44E04
hsa04114 Oocyte meiosis 7 8.97E04
hsa04914 Progesterone-mediated oocyte maturation 5 1.19E02
P-value <0.05 and count >2 were considered threshold values for signiﬁcant difference.
Table 3
Top 10 genes in proteineprotein interaction network.
Gene Degree LogFC Expression
IL6 72 1.825843 Up-regulation
AGT 60 2.100331 Up-regulation
AURKB 55 1.86115 Down-regulation
PLK1 54 1.07164 Down-regulation
BIRC5 54 1.34396 Down-regulation
MMP9 53 2.262069 Up-regulation
FOS 53 1.524809 Up-regulation
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involved in cell cycle (GO: 0007049; 61 DEGs) and M phase (GO:
0000279; 45 DEGs).
As demonstrated in Table 2, KEGG pathway analysis showed that
up-regulated DEGs were primarily enriched in pathways like
cytokineecytokine receptor interaction (hsa04060; 30 DEGs) and
chemokine signaling pathway (hsa04062; 21 DEGs), while down-
regulated DEGs were mainly enriched in pathways such as cell
cycle (hsa04110; 11 DEGs) and p53 signaling (hsa04115; 6 DEGs).CDC20 53 1.16367 Down-regulation
CCNB2 52 1.23723 Down-regulation
MAD2L1 50 1.01054 Down-regulation
Gene represents the name (symbol) for each protein; degree represents the number
of interactions for each gene.PPI network analysis
Total of 2392 protein interactions were revealed with combined
score >0.4 and PPI network was constructed for additional analysis
(Fig. 1). Top 10 hub nodes in PPI network are listed in Table 3. Re-
sults demonstrated that in this PPI network, IL6 (degree: 72), pu-
tative functional angiotensinogen (AGT; degree: 60), matrix
metallopeptidase (MMP9; degree: 53) and c-Fos encoding gene
(FOS; degree: 53) were identiﬁed as up-regulated genes, while
aurora kinase B (AURKB; degree: 55), polo-like Kinase 1 (PLK1;
degree: 54), baculoviral inhibitor of apoptosis (IAP) repeat-
containing 5 (BIRC5; degree: 54), and cell division cycle 20
(CDC20) were identiﬁed as hub down-regulated genes.Prediction of transcriptional regulatory relationship
Transcriptional regulatory network constructed is provided in
Fig. 2. There are 214 up-regulated TF-target pairs and 8 down-
regulated TF-target pairs. Among 214 up-regulated pairs, FOS
regulated many targets, including ADAP2, ADORA3, APOC1, andFig. 1. Proteineprotein interaction network in this study: Red represents up-regulated
gene, green represents down-regulated gene, gray edges represent protein interaction
relationships. Deeper color represents stronger differential expression.
Fig. 2. Transcription factor regulatory network. Red dot represents up-regulated gene,
green dot represents down-regulated gene, red triangle represents up-regulated
transcription factors (TFs), green triangle represents down-regulated TFs, gray edges
represent protein interaction relationships. Deeper color represents stronger differ-
ential expression.APOE, while SPI1 regulated the expression of ACP5, ACTG2, and
ADAP2. Among 8 down-regulated pairs, FOSL1 regulated 8 targets,
including NEK2, TUBB2, ANLN, and FOSL1.
Functional enrichment analysis of integrated sub-network
Integrated modules created after MCODE analysis and inte-
grated analysis are shown in Fig. 3. Module 1 (MCODE score: 18.11)
had 3 primary TFs: SPI1, PRDM1, and FOS, which mainly affected
up-regulated DEGs. Module 2 (MCODE score: 17.619), with FOSL1,
mainly affected down-regulated DEGs. KEGG pathway enrichment
analysis was also processed. Nodes in module 1 were enriched in
pathways such as chemokine signaling pathway (P ¼ 2.04E08),
cytokineecytokine receptor interaction (P ¼ 3.08E07), and
neuroactive ligandereceptor interaction (P ¼ 4.25E06). Nodes in
Fig. 3. Integrated modules of transcription factor regulatory network. Red dot repre-
sents up-regulated gene, green dot represents down-regulated gene, red triangle
represents up-regulated transcription factors (TFs), green triangle represents down-
regulated TFs, gray edges represent protein interaction relationships. Deeper color
represents stronger differential expression.
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(P¼ 4.38E07), oocyte meiosis (P¼ 1.36E05), and progesterone-
mediated oocyte maturation (P ¼ 2.46E04).
Discussion
OA is the most common form of joint disease and the leading
cause of chronic disability in middle-aged and older populations.21
However, pathogenesis and progression of OA is still unclear. In this
study, bioinformatics analysis was performed based on gene
expression proﬁle of SM samples. GO functional enrichment anal-
ysis showed that up- and down-regulated DEGs were primarily
involved in defense response and cell cycle, respectively. KEGG
pathway analysis showed that up- and down-regulated DEGs were
mainly enriched in cytokineecytokine receptor interaction and cell
cycle, respectively. Several key genes, including IL6, AGT, and AURK,
were hub nodes in PPI network.
IL6, a necessary factor for development of musculoskeletal
system, has been proven to play an important role in pathogenesis
of OA.22 A previous study indicated that high production of IL6 is
important immunopathological element for induction of increased
B-cell response region in inﬂamed tissue.23 Franckhauser et al
indicated that chronically elevated IL6 levels could lead to disorder
of skeletal muscles and marked inﬂammation in organ.24 In this
study, IL6 was revealed to be most signiﬁcant up-regulated hub
gene in present PPI network and regulated by FOS. Based on studies
mentioned above, we speculate that IL6 may take part in the pro-
cess of OA via skeletal-related disorder and inﬂammation.AGT is an alpha-2-globulin that is produced constitutively and
released into circulation mainly by the liver. Hong et al conﬁrmed
that angiotensin-converting enzyme (ACE) was a critical factor in
physiology of vasculature, blood pressure, and inﬂammation, and
ACE polymorphism was risk factor for severe form primary knee
OA.25 In addition, renin-angiotensin system could regulate hyper-
trophic differentiation of chondrocytes.26 Furthermore, another
earlier study reported that AGT precursor in synovial ﬂuid partici-
pated in the mechanism of OA by inhibiting proteinase activities.27
In this study, AGT was also a hub node in PPI network, regulated by
SPI1. Therefore, AGT might contribute to process of OA by various
pathways such as inﬂammation.
AURKB functions in attachment of mitotic spindle to centromere
and has been identiﬁed as overexpressed in cancer.28 A previous
study proved that high expression of Aurora kinase A is associated
with unfavorable cytogenetic abnormalities and increased risk of
diseases.29 In gastric cancer, AURKB is associated with low risk of
cancer progression, and over-expression of AURKB can therefore be
used to identify gastric cancer patients with a favorable prog-
nosis.30 However, relationship between AURKB and OA is rare. In
the present study, AURKB was the most signiﬁcant down-regulated
hub gene in PPI network. This result indicates that down-regulation
of AURKB may play a role in the process of OA.
Based on gene expression proﬁles, Zhang et al indicated that cell
cycle pathway is novel therapeutic target for OA.31 Patients with OA
often exhibit inﬂammatory inﬁltrate in SM.9 Chondrocytes, syno-
vial cells, and other cells in the joint can express and respond to
cytokines, which have been detected in synovial ﬂuid of patients
with OA.32 From in vitro and animal model studies of OA, several
cytokines have been identiﬁed as potential targets for OA therapy.33
In present study, cytokineecytokine receptor interaction was the
most signiﬁcant pathway enriched by up-regulated DEGs of OA.
This result indicates that DEGs in this pathway may be vital for
regulation of cytokines, which will further inﬂuence process of OA.
Thus, cell cycle and cytokineecytokine receptor interaction may be
key pathways strongly associated with process of OA.
In conclusion, screened genes, such as IL6, AGT, and AURKB may
be potential targets for gene therapy by being regulated by TFs such
as FOS and SPI1. Moreover, key pathways such as cell cycle and
cytokineecytokine receptor interaction may be important mecha-
nisms in OA development. Although other DEGs identiﬁed in our
study have not been discussed, their roles in OA development merit
further investigation. Thus, bias may exist in our study and role of
these critical genes should be conﬁrmed with experiments such as
reverse transcription polymerase chain reaction and western blot.
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